Annual Shareholders Equity
$213.00 M
-$228.81 M-51.79%
31 December 2023
Summary:
Theravance Biopharma annual stockholders equity is currently $213.00 million, with the most recent change of -$228.81 million (-51.79%) on 31 December 2023. During the last 3 years, it has risen by +$551.57 million (+162.91%). TBPH annual shareholders equity is now -51.79% below its all-time high of $441.80 million, reached on 31 December 2022.TBPH Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$185.65 M
-$8.04 M-4.15%
30 September 2024
Summary:
Theravance Biopharma quarterly stockholders equity is currently $185.65 million, with the most recent change of -$8.04 million (-4.15%) on 30 September 2024. Over the past year, it has dropped by -$27.34 million (-12.84%). TBPH quarterly shareholders equity is now -61.37% below its all-time high of $480.58 million, reached on 30 September 2022.TBPH Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -12.8% |
| 3 y3 years | +162.9% | +154.8% |
| 5 y5 years | +195.2% | +182.9% |
TBPH Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -51.8% | +162.9% | -61.4% | +152.8% |
| 5 y | 5 years | -51.8% | +162.9% | -61.4% | +149.7% |
| alltime | all time | -51.8% | +162.9% | -61.4% | +149.7% |
Theravance Biopharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $185.65 M(-4.1%) |
| June 2024 | - | $193.69 M(-5.5%) |
| Mar 2024 | - | $204.87 M(-3.8%) |
| Dec 2023 | $213.00 M(-51.8%) | $213.00 M(-13.5%) |
| Sept 2023 | - | $246.13 M(-12.1%) |
| June 2023 | - | $280.16 M(-24.4%) |
| Mar 2023 | - | $370.56 M(-16.1%) |
| Dec 2022 | $441.80 M(-230.5%) | $441.80 M(-8.1%) |
| Sept 2022 | - | $480.58 M(-237.4%) |
| June 2022 | - | -$349.81 M(-0.5%) |
| Mar 2022 | - | -$351.45 M(+3.8%) |
| Dec 2021 | -$338.57 M(+11.5%) | -$338.57 M(+4.6%) |
| Sept 2021 | - | -$323.59 M(+7.7%) |
| June 2021 | - | -$300.37 M(-19.5%) |
| Mar 2021 | - | -$373.22 M(+22.9%) |
| Dec 2020 | -$303.75 M(+35.7%) | -$303.75 M(+16.1%) |
| Sept 2020 | - | -$261.54 M(+29.3%) |
| June 2020 | - | -$202.34 M(+28.1%) |
| Mar 2020 | - | -$157.94 M(-29.4%) |
| Dec 2019 | -$223.84 M | -$223.84 M(+22.4%) |
| Sept 2019 | - | -$182.81 M(+33.2%) |
| June 2019 | - | -$137.22 M(+21.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -$113.25 M(+119.5%) |
| Dec 2018 | -$51.59 M(-144.8%) | -$51.59 M(+283.7%) |
| Sept 2018 | - | -$13.45 M(-139.1%) |
| June 2018 | - | $34.39 M(-45.8%) |
| Mar 2018 | - | $63.41 M(-44.9%) |
| Dec 2017 | $115.18 M(-67.1%) | $115.18 M(-37.4%) |
| Sept 2017 | - | $184.12 M(-23.6%) |
| June 2017 | - | $241.13 M(-18.0%) |
| Mar 2017 | - | $293.95 M(-16.1%) |
| Dec 2016 | $350.23 M(+44.1%) | $350.23 M(+17.6%) |
| Sept 2016 | - | $297.87 M(-7.4%) |
| June 2016 | - | $321.58 M(+34.8%) |
| Mar 2016 | - | $238.54 M(-1.9%) |
| Dec 2015 | $243.06 M(-16.1%) | $243.06 M(+9.2%) |
| Sept 2015 | - | $222.54 M(-13.6%) |
| June 2015 | - | $257.67 M(-10.9%) |
| Mar 2015 | - | $289.12 M(-0.2%) |
| Dec 2014 | $289.79 M(-1801.1%) | $289.79 M(-14.7%) |
| Sept 2014 | - | $339.82 M(-11.7%) |
| June 2014 | - | $384.76 M(-2247.6%) |
| Mar 2014 | - | -$17.92 M(+5.2%) |
| Dec 2013 | -$17.04 M | -$17.04 M |
FAQ
- What is Theravance Biopharma annual stockholders equity?
- What is the all time high annual shareholders equity for Theravance Biopharma?
- What is Theravance Biopharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Theravance Biopharma?
- What is Theravance Biopharma quarterly shareholders equity year-on-year change?
What is Theravance Biopharma annual stockholders equity?
The current annual shareholders equity of TBPH is $213.00 M
What is the all time high annual shareholders equity for Theravance Biopharma?
Theravance Biopharma all-time high annual stockholders equity is $441.80 M
What is Theravance Biopharma quarterly stockholders equity?
The current quarterly shareholders equity of TBPH is $185.65 M
What is the all time high quarterly shareholders equity for Theravance Biopharma?
Theravance Biopharma all-time high quarterly stockholders equity is $480.58 M
What is Theravance Biopharma quarterly shareholders equity year-on-year change?
Over the past year, TBPH quarterly stockholders equity has changed by -$27.34 M (-12.84%)